Clinical Trials Browser

Non-Muscle Invasive Bladder Neoplasms

NCT07339761 2026-01-14

SPICE

Phase NA Recruiting

30 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07187063 2025-09-22

Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer

Phase NA Recruiting

56 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT07036731 2025-06-25

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

Phase NA Recruiting

428 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Fanconi Syndrome

NCT06889623 2025-03-21

HIGCrecur

Phase NA Recruiting

72 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT06735287 2025-03-18

A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer

Phase NA Recruiting

60 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05790850 2024-12-16

PRIMER

Phase NA Recruiting

30 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Motor Activity

NCT06287541 2024-03-01

The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection

Phase NA Recruiting

428 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Fanconi Syndrome

Clinical Trials

Hydeal Cyst

SPICE

Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

HIGCrecur

A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer

PRIMER

The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection